- Dr. Jasjeet Singh Wasir is an eminent Endocrinologist, practicing successfully for more than 20 years.
- He is skilled in Weight Management (Obesity) for Diabetes, Assessment of Heart Attack risk for diabetes patients, Controlling and preventing Heart Attack for diabetes patients.
- He is one of the primary faculty members of Centre for Advanced Diabetes Therapy and Technology.
- He plays the pivotal role in conducting Weight Management Programme at Medanta under the guidance of Dr. Ambarish Mittal.
- He is a member of Medical Council of India (MCI).
Dr. Jasjeet Singh Wasir
- Endocrinologist
- Associate Director MD, MBBS,20 years of experience
- Medanta - The Medicity Hospital
- Gurgaon
Dr. Jasjeet Singh Wasir
- Endocrinologist
- Associate Director MD, MBBS,20 years of experience
- Medanta - The Medicity Hospital
- Gurgaon
Profile (Overview)
Specialities
Specialization
- Plantar Fascitis
- Peritoneal Dialysis Lactation Counseling
- Congenital Disorders
- Rheumatic Heart Disease
- Typhoid Fever
- Dengue Fever
- Pituitary Diseases
- Diabetes, Obesity
- Thyroid disorders etc
Work Experience of Dr. Jasjeet Singh Wasir
- Consultant, Sadhu Vaswani Mission Medical Centre, New Delhi
Education
- MD, 2001, University College of Medical Sciences, Delhi University
- MBBS, 1997, Maulana Azad Medical College, Delhi University
Awards
Paper Published
- Associated with research and has published several articles in noted national and international journals:
- A Demonstration Project to Evaluate the Effectiveness and Acceptability of the Joint Asia Diabetes Evaluation (JADE) & Diabetes Monitoring Database (DIAMOND) Programs in Type 2 Diabetic Patients in India.
- ASURF (Asian Study for Evaluation of Cardiovascular Risk Factors). 2013.
- Phenotypic and Genetic Correlates of Diabetes (Non-Type 1). in Young Non-obese Asian Indians in North India and a Pilot Case Control Study to Evaluate the Efficacy of Sitagliptin (DPP-4 inhibitor) in a Sub-group of the Study Population.
- A Phase IIb/IIIa randomized, placebo controlled clinical trial to study the safety and efficacy of MK-0364 in overweight and obese patients with Type 2 Diabetes.
- A case control study to evaluate the effects of a multi-nutritional supplement ‘Protinex-Diabetes’ on metabolic and anthropometric parameters in adult subjects with Type 2 Diabetes Mellitus.
